Open Access
Numéro
Med Sci (Paris)
Volume 40, Numéro 1, Janvier 2024
La cavité orale et les dents au cœur de la santé
Page(s) 49 - 56
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2023195
Publié en ligne 1 février 2024
  1. Suárez LJ, Garzón H, Arboleda S et al. Oral Dysbiosis and Autoimmunity: From Local Periodontal Responses to an Imbalanced Systemic Immunity. A Review. Front Immunol 2020; 11 : 591255. [CrossRef] [PubMed] [Google Scholar]
  2. Wang L, Wang F-S, Gershwin ME. Human autoimmune diseases: A comprehensive update. J Intern Med 2015 ; 278 : 369–395. [CrossRef] [PubMed] [Google Scholar]
  3. Ruff WE, Greiling TM, Kriegel MA. Host-microbiota interactions in immune-mediated diseases. Nat Rev Microbiol 2020; 18 : 521–38. [CrossRef] [PubMed] [Google Scholar]
  4. Claessens YE, Mouthon L. Maladies rares en médecine d’urgence: définition et classification des maladies auto-immunes. Références en médecine d’urgence. Collection de la SFMU 2013, Chap 1 : 1–12. [Google Scholar]
  5. Saccucci M, Di Carlo G, Bossù Met al. Autoimmune diseases and their manifestations on oral cavity : Diagnosis and clinical management. J Immunol Res 2018 ; 2018 : 6061825. [CrossRef] [Google Scholar]
  6. Vaillant L, Chauchaix-Barthès S, Hüttenberger B, et al. Le syndrome « gingivite érosive chronique » : Étude rétrospective de 33 cas. Annales de dermatologie et de vénéréologie 2000; 127 : 381–7. [Google Scholar]
  7. Bach JF. Revisiting the Hygiene Hypothesis in the Context of Autoimmunity. Front Immunol 2021; 11 : 615192. [CrossRef] [PubMed] [Google Scholar]
  8. De Luca F, Shoenfeld Y. The microbiome in autoimmune diseases. Clin Exp Immunol 2019 ; 195 : 74–85. [Google Scholar]
  9. Harrington LE, Hatton RD, Mangan PRet al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005 ; 6 : 1123–1132. [CrossRef] [PubMed] [Google Scholar]
  10. Ortiz Wilczyñski JM, Olexen CM, Errasti AE, et al. GAS6 signaling tempers Th17 development in patients with multiple sclerosis and helminth infection. PLoS Pathog 2020; 16 : e1009176. [CrossRef] [PubMed] [Google Scholar]
  11. Dutzan N, Kajikawa T, Abusleme L, et al. A dysbiotic microbiome triggers TH17 cells to mediate oral mucosal immunopathology in mice and humans. Sci Transl Med 2018; 10 : eaat0797. [CrossRef] [PubMed] [Google Scholar]
  12. Yokota SI, Hirata D, Minota Set al. Autoantibodies against chaperonin CCT in human sera with rheumatic autoimmune diseases: comparison with antibodies against other Hsp60 family proteins. Cell Stress Chaperones 2000 ; 5 : 337–346. [CrossRef] [PubMed] [Google Scholar]
  13. Miller WB. The Eukaryotic Microbiome: Origins and Implications for Fetal and Neonatal Life. Front Pediat 2016 ; 4 : 96. [CrossRef] [Google Scholar]
  14. Kobayashi R, Ogawa Y, Hashizume-Takizawa T, et al. Oral bacteria affect the gut microbiome and intestinal immunity. Pathog Dis 2020; 78 : ftaa024. [CrossRef] [PubMed] [Google Scholar]
  15. Atarashi K, Suda W, Luo C, Kawaguchi T, et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science 2017 ; 358 : 359–365. [CrossRef] [PubMed] [Google Scholar]
  16. Giordano-Kelhoffer B, Lorca C, March Llanes J, et al. Oral Microbiota, Its Equilibrium and Implications in the Pathophysiology of Human Diseases: A Systematic Review. Biomedicines 2022; 10 : 1803. [CrossRef] [PubMed] [Google Scholar]
  17. Siddiqui H, Chen T, Aliko Aet al. Microbiological and bioinformatics analysis of primary Sjogren’s syndrome patients with normal salivation. J Oral Microbiol 2016 ; 8 : 31119. [CrossRef] [PubMed] [Google Scholar]
  18. Otsuka K, Sato M, Tsunematsu T, et al. Virus Infections Play Crucial Roles in the Pathogenesis of Sjögren’s Syndrome. Viruses 2022; 14 : 1474. [CrossRef] [PubMed] [Google Scholar]
  19. Masuko K. Will the COVID-19 pandemic trigger future occurrence of autoimmunity like Sjögren’s syndrome?. Int J Rheum Dis 2021; 24 : 963–5. [CrossRef] [PubMed] [Google Scholar]
  20. Krutyholowa A, Strzelec K, Dziedzic A, et al. Host and bacterial factors linking periodontitis and rheumatoid arthritis. Front Immunol 2022; 13 : 980805. [CrossRef] [PubMed] [Google Scholar]
  21. Laugisch O, Wong A, Sroka Aet al. Citrullination in the periodontium—A possible link between periodontitis and rheumatoid arthritis. Clin Oral invest 2016 ; 20 : 675–683. [CrossRef] [PubMed] [Google Scholar]
  22. Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol 2021; 21 : 426–40. [CrossRef] [PubMed] [Google Scholar]
  23. De Pablo P, Chapple IL, Buckley CDet al. Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol 2009 ; 5 : 218–224. [CrossRef] [PubMed] [Google Scholar]
  24. Potempa J, Mydel P, Koziel J. The case for periodontitis in the pathogenesis of rheumatoid arthritis. Nat Rev Rheumatol 2017 ; 13 : 606–620. [CrossRef] [PubMed] [Google Scholar]
  25. Maresz KJ, Hellvard A, Sroka Aet al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog 2013 ; 9 : e1003627. [CrossRef] [PubMed] [Google Scholar]
  26. Gully N, Bright R, Marino Vet al. Porphyromonas gingivalis peptidylarginine deiminase, a key contributor in the pathogenesis of experimental periodontal disease and experimental arthritis. PLoS One 2014 ; 9 : e100838. [Google Scholar]
  27. Konig MF, Abusleme L, Reinholdt J, et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med 2016; 8 : 369ra176. [CrossRef] [PubMed] [Google Scholar]
  28. Martinez-Martinez RE, Abud-Mendoza C, Patiño-Marin N, et al. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol 2009 ; 36 : 1004–1010. [CrossRef] [PubMed] [Google Scholar]
  29. Payne JB, Golub L. M Thiele GM, et al. The link between periodontitis and rheumatoid arthritis : A periodontist’s perspective. Curr Oral health Rep 2015 ; 2 : 20–29. [CrossRef] [PubMed] [Google Scholar]
  30. Golub LM PB, Reinhart RA, et al. Can systemic diseases co-induce (not just exacerbate) periodontitis? A hypothetical “two-hit” model. J Dental Res 2006 ; 85 : 102–105. [CrossRef] [PubMed] [Google Scholar]
  31. Mays JW, Sarmadi M, Moutsopoulos NM. Oral Manifestations of Systemic Autoimmune and Inflammatory Diseases : Diagnosis and Clinical Management. J Evid Based Dent Pract 2012 ; 12 : 265–282. [CrossRef] [PubMed] [Google Scholar]
  32. Benli M, Batool F, Stutz C, et al. Orofacial manifestations and dental management of systemic lupus erythematosus : A review. Oral Dis 2021; 27 : 151–67. [CrossRef] [PubMed] [Google Scholar]
  33. Negrini S, Emmi G, Greco M, et al. Sjögren’s syndrome : A systemic autoimmune disease. Clin Exp Med 2022; 22 : 9–25. [CrossRef] [PubMed] [Google Scholar]
  34. Benz K, Baulig C, Knippschild S, et al. Prevalence of Oral and Maxillofacial Disorders in Patients with Systemic Scleroderma-A Systematic Review. Int J Environ Res Public Health 2021; 18 : 5238. [CrossRef] [PubMed] [Google Scholar]
  35. Siar CH, Yeo KB, Nakano Ket al. Strawberry gingivitis as the first presenting sign of Wegener’s granulomatosis: report of a case. Eur J Med Res 2011 ; 16 : 331–334. [CrossRef] [PubMed] [Google Scholar]
  36. Zhu F, Ang JY. 2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease. Curr Infect Dis Rep 2021; 23 : 3. [CrossRef] [PubMed] [Google Scholar]
  37. Bouaziz A., Le Scanff J., Chapelon-Abric C, et al. Oral involvement in sarcoidosis : Report of 12 cases. QJM 2012; 105 : 755–67. [CrossRef] [PubMed] [Google Scholar]
  38. Ramos-e-Silva M., Ferreira A, De-Moura-Castro JC.. Oral involvement in autoimmune bullous diseases. Clin Dermatol 2011 ; 29 : 443–454. [CrossRef] [PubMed] [Google Scholar]
  39. Sahin T, Brygo A, Delaporte Eet al. Les manifestations orales de la maladie de Crohn. Swiss Dent J 2017 ; 127 : 644–653. [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.